ArticleInvestigational new drugs2025
Direct functional HOXA9/DNA-binding competitors versus epigenetic inhibitors of HOXA9 expression on cell proliferation, death and differentiation processes in the model of MLL-rearranged acute myeloid leukemia.
Julie Vrevin et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it